These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The use of routinely available clinical data in differentiating renal allograft rejection from cyclosporine nephrotoxicity. Chan GL; Hodge EE; Chang HH Transplantation; 1989 Dec; 48(6):1075-7. PubMed ID: 2595772 [No Abstract] [Full Text] [Related]
4. Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection. Veremis SA; Maddux MS; Tang IY; Millner SN; Prasad R; Pollak R; Mozes MF Transplant Proc; 1989 Feb; 21(1 Pt 2):1476-7. PubMed ID: 2652473 [No Abstract] [Full Text] [Related]
5. The clinical significance of urinary fibrinopeptide A and fibrinopeptide B-beta 15-42 in chronic rejection and nephrotoxicity of renal allograft recipients immunosuppressed with cyclosporine. Morozumi K; Kano T; Kobayashi M; Shinmura I; Yoshida A; Fujinami T; Otaguro K; Uchida K; Yamada N; Tominaga Y Transplant Proc; 1987 Feb; 19(1 Pt 2):1791-4. PubMed ID: 3547884 [No Abstract] [Full Text] [Related]